// App-Quantinova.ai

: A randomized trial to determine the effect of glycopyrrolate/formoterol on exercise tolerance in COPD: influence of dynamic hyperinflation and dead space ventilation

Researchers

Presenter

  • William Stringer

Principal Investigators

  • Janos Porszasz

  • Michael Von Plato

  • Arash Khosrovi-Eghbal

  • Mohan Zopey

  • Min Cao

  • April Soriano

  • Robert Calmelat

  • Harry Rossiter

  • Agustin Leyva

  • Shahid Siddiqui

  • Stephen Rennard

  • Richard Casaburi

Medical Centers

  • Los Angeles Biomedical Institute (LABIOMED) at Harbor-UCLA Medical Center, Torrance, CA, United States of America

  • AstraZeneca, Gaithersberg, MD, United States,

  • Oncology IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • Formoterol/glycopyrrolate

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Cross Over

  • Double Blind/Blinded

  • Controlled

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved